blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4378461

EP4378461 - LIPID BILAYER COATED MESOPOROUS SILICA NANOPARTICLES WITH A HIGH LOADING CAPACITY FOR ONE OR MORE ANTICANCER AGENTS [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  03.05.2024
Database last updated on 03.09.2024
Most recent event   Tooltip08.08.2024Publication of search reportpublished on 11.09.2024 [2024/37]
08.08.2024Change - classificationpublished on 11.09.2024 [2024/37]
08.08.2024Change - classificationpublished on 11.09.2024 [2024/37]
Applicant(s)For all designated states
The Regents of University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607-5200 / US
[2024/23]
Inventor(s)01 / NEL, Andre E.
California, 90095-7305 / US
02 / ZINK, Jeffrey I.
California, 90095-1569 / US
03 / MENG, Huan
California, 90095-1781 / US
 [2024/23]
Representative(s)Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
[2024/23]
Application number, filing date24156880.705.03.2014
[2024/23]
Priority number, dateUS201361773013P05.03.2013         Original published format: US 201361773013 P
US201361858388P25.07.2013         Original published format: US 201361858388 P
[2024/23]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4378461
Date:05.06.2024
Language:EN
[2024/23]
Type: A3 Search report
No.:EP4378461
Date:11.09.2024
Language:EN
[2024/37]
Search report(s)(Supplementary) European search report - dispatched on:EP12.08.2024
ClassificationIPC:A61K9/16, A61K9/127, A61K47/02, A61P35/00
[2024/37]
CPC:
A61K9/127 (EP,US); A61K31/337 (EP,US); A61K31/4709 (EP,US);
A61K31/7068 (EP,US); A61K31/7105 (EP,US); A61K31/713 (EP,US);
A61K45/06 (EP,US); A61K47/02 (US); A61K9/5115 (EP,US);
A61P35/00 (EP) (-)
C-Set:
A61K31/337, A61K2300/00 (US,EP);
A61K31/4709, A61K2300/00 (US,EP);
A61K31/7068, A61K2300/00 (EP,US);
A61K31/7105, A61K2300/00 (US,EP);
A61K31/713, A61K2300/00 (EP,US)
(-)
Former IPC [2024/23]A61K31/4709
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/23]
TitleGerman:MIT EINER LIPIDDOPPELSCHICHT BESCHICHTETE MESOPORÖSE SILICIUMDIOXIDNANOTEILCHEN MIT HOHER LADEKAPAZITÄT FÜR EIN ODER MEHRERE ANTIKREBSMITTEL[2024/23]
English:LIPID BILAYER COATED MESOPOROUS SILICA NANOPARTICLES WITH A HIGH LOADING CAPACITY FOR ONE OR MORE ANTICANCER AGENTS[2024/23]
French:NANOPARTICULES DE SILICE MÉSOPOREUSE REVÊTUES D'UNE BICOUCHE LIPIDIQUE PRÉSENTANT UNE CAPACITÉ DE CHARGE ÉLEVÉE POUR UN OU PLUSIEURS AGENTS ANTICANCÉREUX[2024/23]
Parent application(s)   TooltipEP14760467.2  / EP2964201
Fees paidRenewal fee
09.02.2024Renewal fee patent year 03
09.02.2024Renewal fee patent year 04
09.02.2024Renewal fee patent year 05
09.02.2024Renewal fee patent year 06
09.02.2024Renewal fee patent year 07
09.02.2024Renewal fee patent year 08
09.02.2024Renewal fee patent year 09
09.02.2024Renewal fee patent year 10
09.02.2024Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inby applicantUS20100255103
 US20100284924
 US20100310465
 US20120021034
 US20130046274
 US20120207795
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.